No phaseRecruiting
Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers (Myokinesis)
- Sponsor
- Institut de Myologie, France (Academic or other)
- Enrollment
- 30 planned
- Conditions
- Spinal Muscular Atrophy (SMA); Charcot-Marie-Tooth; Muscular Dystrophy; Myotonic Dystrophy
- Interventions
- Gait analysis via video capture
- Ages
- adults, older adults
- Registry
- NCT07321977
Full record on ClinicalTrials.gov
From the registry
In recent years, knowledge of neuromuscular diseases has advanced considerably, and new therapeutic avenues are beginning to emerge. The proliferation of clinical trials has created a need to identify biomarkers that are both sensitive to changes and specific to the disease. Current gait tests only consider the time factor and not the evolution of the patient's biomechanics, which may prove insufficient for patients whose symptoms generally progress slowly. Quantifying gait parameters in neuromuscular patients therefore appears necessary. This is why we propose to study markerless gait analysis in this population, which would allow for simple and effective monitoring of kinematic parameters without resorting to complex equipment incompatible with routine clinical practice.
Primary outcomes
- Vicon vs Myokinesis system correlation coefficient
History
Primary completion expected
Last registry update
Started
Registered